Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia
暂无分享，去创建一个
M. Dyer | T. Kipps | S. Stilgenbauer | F. Hernandez-Ilizaliturri | T. Robak | W. Wierda | M. Trněný | A. Österborg | R. Furman | S. Lisby | G. Cartron | S. Padmanabhan | G. Chan | J. Mayer | P. Hillmen | N. Losic | Cathy D. Williams | I. Gupta | Randy L. Davis | M. Gorczyca | C. Williams